TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2142580

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (30 micrograms) combined with gestodene (75 micrograms)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol (30 micrograms) combined with desogestrel (150 micrograms)
Number of subjects: 60
Study: 6197010

Group type: EXPERIMENTAL
Intervention: Measles vaccine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vitamin B12 injection (Control)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Well-nourished children (Control)
Number of subjects: 70
Study: 30892564

Group type: EXPERIMENTAL
Intervention: Self-guided app-based VR CBT (n = 96)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Wait-list control group (n = 97)
Number of subjects: 193
Study: 29536296

Group type: EXPERIMENTAL
Intervention: Intraperitoneal paclitaxel (60 mg/m2 on days 0, 14, 21, 28, 42, 49, and 56)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Intravenous paclitaxel (80 mg/m2 on the same schedule)
Number of subjects: 83
Study: 26872608

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg Q2W
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 25260232

Group type: EXPERIMENTAL
Intervention: C-Qur™ Film
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (no adhesion barrier)
Number of subjects: 84
Study: 23968742

Group type: EXPERIMENTAL
Intervention: Nutrition and activity education+behavioral intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nutrition and activity education
Number of subjects: 21
Study: 20959311

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 416

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 416
Study: 17908256

Group type: EXPERIMENTAL
Intervention: Dispersive-viscoadaptive soft-shell technique using Viscoat and Healon 5 (V-group)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Dispersive-cohesive soft-shell technique with Viscoat and Opegan-Hi (C-group)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Dispersive-viscoadaptive soft-shell technique (V-group) with ultrasound of 10 %Min or less
Number of subjects: 171

Group type: COMPARATOR
Intervention: Dispersive-cohesive soft-shell technique (C-group) with ultrasound of 10 %Min or less
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Dispersive-viscoadaptive soft-shell technique (V-group) with ultrasound of over 10 %Min
Number of subjects: 171

Group type: COMPARATOR
Intervention: Dispersive-cohesive soft-shell technique (C-group) with ultrasound of over 10 %Min
Number of subjects: 171
Study: 16055155

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at the left dorsolateral prefrontal cortex (DLPFC) (40 trains of 2 s duration, 20 Hz stimuli)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 0
Study: 12627499

Group type: EXPERIMENTAL
Intervention: Axillary dissection
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Breast radiation
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 370
Study: 10371789

Group type: EXPERIMENTAL
Intervention: i.v. procainamide
Number of subjects: 136

Group type: COMPARATOR
Intervention: DC shock
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Left atrial size
Number of subjects: 136
Study: 8791972

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 12
Study: 1869405

Group type: EXPERIMENTAL
Intervention: Epinephrine 2% drops administered twice a day for 2 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administered twice a day for 2 weeks
Number of subjects: 18
Study: 7065469

Group type: EXPERIMENTAL
Intervention: lodoxamide ethyl
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Direct measurement of area by planimetry
Number of subjects: 10
Study: 30609202

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 9
Study: 30239552

Group type: EXPERIMENTAL
Intervention: High-β-carotene tomato juice (30.4 mg of β-carotene)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-lycopene tomato juice (42.5 mg of lycopene)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Carotenoid-free control (cucumber juice)
Number of subjects: 35
Study: 27405054

Group type: EXPERIMENTAL
Intervention: Bolus feeding (BF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Slow infusion feeding (SF)
Number of subjects: 10
Study: 24467807

Group type: EXPERIMENTAL
Intervention: Affect Regulation Training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active common factor based treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 120
Study: 23290065

Group type: EXPERIMENTAL
Intervention: Rehabilitation robot for lower-limb training (10-20 min/d, 6 d/week for 8 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Neuro-facilitation technique (control group)
Number of subjects: 48
Study: 20378197

Group type: EXPERIMENTAL
Intervention: Glargine insulin therapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: NPH insulin therapy
Number of subjects: 138
Study: 17951477

Group type: EXPERIMENTAL
Intervention: Quercetin 730 mg/d for 28 d
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 15079026

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric symptoms (NPI+)
Number of subjects: 1010

Group type: COMPARATOR
Intervention: No neuropsychiatric symptoms (NPI-)
Number of subjects: 1010
Study: 12572723

Group type: EXPERIMENTAL
Intervention: Ozonized sunflower oil (Oleozon) applied twice per day for 6 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ketoconazole cream 2% (Nizoral) applied twice per day for 6 weeks
Number of subjects: 200
Study: 9703599

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasonography of the parietal wall for the diagnosis of peritoneal adhesions
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Hazardous laparoscopic maneuvers
Number of subjects: 130
Study: 8591497

Group type: EXPERIMENTAL
Intervention: ComputerLink (experimental group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 2669667

Group type: EXPERIMENTAL
Intervention: 4.6 g/d of omega-3 fatty acids
Number of subjects: 8

Group type: COMPARATOR
Intervention: corn oil (5.4 g/d linoleic acid)
Number of subjects: 8
Study: 579116

Group type: EXPERIMENTAL
Intervention: Tibric acid (1.5 g daily for 1 year)
Number of subjects: 20
Study: 31610436

Group type: EXPERIMENTAL
Intervention: CBM‐I interpretation training
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control CBM‐I training
Number of subjects: 89
Study: 30520424

Group type: EXPERIMENTAL
Intervention: 7-day removal
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Spontaneous detachment
Number of subjects: 230

Group type: COMPARATOR
Intervention: 7-day removal vs Spontaneous detachment
Number of subjects: 230
Study: 28189191

Group type: EXPERIMENTAL
Intervention: Exercise intervention (aerobic, resistance, and inspiratory muscle training)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 20
Study: 25801289

Group type: EXPERIMENTAL
Intervention: THC administration
Number of subjects: 20
Study: 24225780

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgical therapy
Number of subjects: 20
Study: 22046718

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Greater level of education
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Non-Hispanic ethnicity
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Behaviorally active coping style
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: General physical health
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Role-related emotional health
Number of subjects: 460
Study: 19246160

Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 16822127

Group type: EXPERIMENTAL
Intervention: Temporally structured flicker in the gamma band
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asynchronous priming of vertices corresponding to distinct Kanizsa-type rectangles
Number of subjects: 0
Study: 12784346

Group type: EXPERIMENTAL
Intervention: Aprepitant plus standard therapy (ondansetron 32 mg IV and dexamethasone 20 mg on Day 1; dexamethasone 8 mg twice daily on Days 2-4)
Number of subjects: 523

Group type: COMPARATOR
Intervention: Standard therapy (ondansetron 32 mg IV and dexamethasone 20 mg on Day 1; dexamethasone 8 mg twice daily on Days 2-4)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Aprepitant plus standard therapy
Number of subjects: 523

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 523
Study: 11006251

Group type: EXPERIMENTAL
Intervention: Methazolamide 1% in cyclodextrin solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dorzolamide (Trusopt)
Number of subjects: 8
Study: 8835708

Group type: EXPERIMENTAL
Intervention: Paroxetine (PAR), 20 mg/day
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 1445103

Group type: EXPERIMENTAL
Intervention: 100 mls of Iopamiro 370 at 2 mls/sec scanning inferosuperiorly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 100 mls of Iopamiro 370 at 2 mls/sec scanning superoinferiorly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 100 mls of Iopamiro 370 at 1 ml/sec scanning inferosuperiorly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mls of Iopamiro 370 at 1 ml/sec scanning inferosuperiorly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 40 mls hand injected bolus followed by 60 ml pump infusion at 1.3 mls/sec scanning inferosuperiorly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 mls hand injected bolus scanning inferosuperiorly
Number of subjects: 90
Study: 2996575

Group type: EXPERIMENTAL
Intervention: Enalapril (n = 13)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 25
Study: 31538907

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (2 capsules containing 500 mg of phosphatidylcholine complex of curcumin)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (two 500 mg placebo capsules)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 29248657

Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac CT protocol
Number of subjects: 268
Study: 27324599

Group type: EXPERIMENTAL
Intervention: Sexual healthcare training programme (4 weeks, 16 hours)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no training programme)
Number of subjects: 117
Study: 24440362

Group type: EXPERIMENTAL
Intervention: Posterolateral hip muscle strengthening
Number of subjects: 36

Group type: COMPARATOR
Intervention: Quadriceps strengthening
Number of subjects: 36
Study: 23054866

Group type: EXPERIMENTAL
Intervention: TPN with additional trace elements for 28 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) alone for 28 days
Number of subjects: 18
Study: 20410232

Group type: EXPERIMENTAL
Intervention: High-fat overfeeding (+50% calories)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 46
Study: 19093919

Group type: EXPERIMENTAL
Intervention: Care Management Plus (CMP) with nurse care managers supported by specialized information technology
Number of subjects: 3432

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3432
Study: 15500091

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy (LG) with lymph node dissection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemosensitivity test-guided chemotherapy
Number of subjects: 0
Study: 10917407

Group type: EXPERIMENTAL
Intervention: MDMA-125 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amphetamine-40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MDMA-125 mg and MDMA-75 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 8
Study: 9207617

Group type: EXPERIMENTAL
Intervention: Beta-blockade treatment
Number of subjects: 3039

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 3039

Group type: EXPERIMENTAL
Intervention: Non-carvedilol drugs
Number of subjects: 3039
Study: 8365381

Group type: EXPERIMENTAL
Intervention: 40 mg of zinc as zinc sulphate
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 3510848

Group type: EXPERIMENTAL
Intervention: High-dosage oral metoclopramide (three times 50 mg) with prednisone (three times 25 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: High-dosage oral metoclopramide (three times 50 mg) without prednisone
Number of subjects: 58
Study: 29742550

Group type: EXPERIMENTAL
Intervention: Activity tracker (Fitbit Zip) connected to an online lifestyle program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Responders (56%, increasing minimally 1000 steps/d)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nonresponders
Number of subjects: 72
Study: 27479174

Group type: EXPERIMENTAL
Intervention: KI polyomavirus infection
Number of subjects: 1077

Group type: EXPERIMENTAL
Intervention: WU polyomavirus infection
Number of subjects: 1077
Study: 24907689

Group type: EXPERIMENTAL
Intervention: 500ml of a mixed-nutrient drink (750kcal) 30 min prior to meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 500ml of a mixed-nutrient drink (750kcal) 90 min prior to meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 500ml of a mixed-nutrient drink (750kcal) 180 min prior to meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: 500ml of water 180 min prior to meal (control)
Number of subjects: 16
Study: 22549281

Group type: EXPERIMENTAL
Intervention: ACE inhibition (ramipril 5 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ARB (candesartan 16 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19513578

Group type: EXPERIMENTAL
Intervention: Kyphoplasty (5.56 +/- 0.62 mL of PMMA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vertebroplasty (4.91 +/- 0.65 mL of PMMA)
Number of subjects: 100
Study: 18392240

Group type: EXPERIMENTAL
Intervention: Postprandial walking (4 km/h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Postprandial consumption of alcoholic digestifs (brandy, herb flavored liqueur, Williams pear brandy, aquavit, espresso)
Number of subjects: 10
Study: 16153933

Group type: EXPERIMENTAL
Intervention: Triiodothyronine (0.05 micro/kg/h) for 72 hours after cardiopulmonary bypass
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 12942852

Group type: EXPERIMENTAL
Intervention: 10 mg Lutéran tablet
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5 mg Lutéran tablets (control)
Number of subjects: 12
Study: 10397377

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 400 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 800 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 1200 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 1600 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 8889461

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pantoprazole 80 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pantoprazole 120 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: No therapy (control)
Number of subjects: 15
Study: 1996921

Group type: EXPERIMENTAL
Intervention: Arecoline hydrobromide (1.0 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arecoline hydrobromide (0.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6508224

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Enflurane anaesthesia
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Anaesthesia without volatile agent
Number of subjects: 49

Group type: COMPARATOR
Intervention: Postoperative T-tube group (Control)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All anaesthetized groups
Number of subjects: 49
Study: 31159793

Group type: EXPERIMENTAL
Intervention: e-Learning resources (Group A)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Post-test questionnaire on e-Learning resources
Number of subjects: 19
Study: 29523557

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (including stent retriever thrombectomy, aspiration, and alternative methods)
Number of subjects: 1488

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 1488
Study: 28157671

Group type: EXPERIMENTAL
Intervention: Wheat germ-enriched bread (6 g of wheat germ)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-enriched bread (control)
Number of subjects: 55
Study: 23952739

Group type: EXPERIMENTAL
Intervention: Silicone gel applied twice a day after stitches removal
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tretinoin cream applied twice a day after stitches removal
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study: 22610181

Group type: EXPERIMENTAL
Intervention: Negative mean daily fluid balance
Number of subjects: 1453
Study: 19092551

Group type: EXPERIMENTAL
Intervention: Nurse-case-managed sessions plus targeted hepatitis education, incentives, and tracking (NCMIT)
Number of subjects: 865

Group type: COMPARATOR
Intervention: Standard targeted hepatitis education plus incentives and tracking (SIT)
Number of subjects: 865

Group type: COMPARATOR
Intervention: Standard targeted hepatitis education and incentives only (SI)
Number of subjects: 865
Study: 17319887

Group type: EXPERIMENTAL
Intervention: Written information about communicating with family and basic organ donation information
Number of subjects: 109

Group type: COMPARATOR
Intervention: Basic organ donation information only
Number of subjects: 109
Study: 15207898

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg per day)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Toremifene (40 mg per day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Post-treatment (1 year after cessation of anti-estrogen)
Number of subjects: 70
Study: 11306202

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens at 0.625 mg/d plus trimonthly medroxyprogesterone acetate at 5 mg/d for 13 days (HRT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 9141148

Group type: EXPERIMENTAL
Intervention: Intravenously injected human corticotropin releasing factor (hCRF)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Combined 5-minute stress test
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy young men)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Older healthy subjects and alcoholics
Number of subjects: 21
Study: 10137793

Group type: EXPERIMENTAL
Intervention: Prescription drug coverage for new enrollees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-cost drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low users of prescription drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established enrollees
Number of subjects: 0
Study: 3312032

Group type: EXPERIMENTAL
Intervention: Ceftazidime alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus tobramycin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Azlocillin plus tobramycin
Number of subjects: 50
Study: 28816072

Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Electrochemotherapy (bleomycin)
Number of subjects: 7
Study: 27317971

Group type: EXPERIMENTAL
Intervention: Calories, Sodium, + Contextual Statement (CS) menu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calories + Contextual Statement (CS) menu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditions providing sodium information
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Nutrition Information, Calories‐Only, Calories + CS, Calories, Sodium, + CS, Calorie and Sodium in Traffic Lights + CS
Number of subjects: 0
Study: 25264047

Group type: EXPERIMENTAL
Intervention: Mekabu (70 g) with a white rice-based breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wakame with a white rice-based breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control meal (without Mekabu or Wakame)
Number of subjects: 0
Study: 21814218

Group type: EXPERIMENTAL
Intervention: Calorie-restricted diet (D)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of D+EX
Number of subjects: 30

Group type: COMPARATOR
Intervention: D alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: EX alone
Number of subjects: 30
Study: 20819421

Group type: EXPERIMENTAL
Intervention: Amino acid mixture 0.76 g/day
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Amino acid mixture 1.52 g/day
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Amino acid mixture 1.52 g/day coadministered with conjugated linoleic acid 1.6 g/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 18417744

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (50% dose increase at randomization)
Number of subjects: 321
Study: 15629985

Group type: EXPERIMENTAL
Intervention: Olfactory stimulation (pleasant odor diffused during 24 hours in the incubator)
Number of subjects: 14
Study: 12591556

Group type: EXPERIMENTAL
Intervention: Extruded formulated complementary diet from maize and cowpea (L(1)A(1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Above-average socioeconomic background (HN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (L(2)N)
Number of subjects: 30